Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis

REFERENCES

1. 1.↵
   2. Wong KS,
   3. Li H

   . Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003;34:2361–66 doi:10.1161/01.STR.0000089017.90037.7A pmid:12947158

   Abstract/FREE Full Text
2. 2.↵
   2. Wang Y,
   3. Zhao X,
   4. Liu L, et al

   ; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) study. Stroke 2014;45:663–69 doi:10.1161/STROKEAHA.113.003508 pmid:24481975

   Abstract/FREE Full Text
3. 3.↵
   2. Chimowitz MI,
   3. Lynn MJ,
   4. Howlett-Smith H, et al

   ; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16 doi:10.1056/NEJMoa043033 pmid:15800226

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Fiorella D,
   3. Levy EI,
   4. Turk AS, et al

   . US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87 doi:10.1161/01.STR.0000257963.65728.e8 pmid:17290030

   Abstract/FREE Full Text
5. 5.↵
   2. Cruz-Flores S,
   3. Diamond AL

   . Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006;CD004133 pmid:16856032

   PubMed
6. 6.↵
   2. Ma N,
   3. Mo DP,
   4. Gao F, et al

   . Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion. J Neurointerv Surg 2013;5:e15 doi:10.1136/neurintsurg-2012-010304 pmid:22496065

   Abstract/FREE Full Text
7. 7.↵
   2. Aghaebrahim A,
   3. Jovin T,
   4. Jadhav AP, et al

   . Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries. J Neurointerv Surg 2014;6:645–48 doi:10.1136/neurintsurg-2013-010842 pmid:24249733

   Abstract/FREE Full Text
8. 8.↵
   2. Chimowitz MI,
   3. Lynn MJ,
   4. Derdeyn CP, et al

   ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003 doi:10.1056/NEJMoa1105335 pmid:21899409

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Derdeyn CP,
   3. Chimowitz MI,
   4. Lynn MJ, et al

   ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 2014;383:333–41 doi:10.1016/S0140-6736(13)62038-3 pmid:24168957

   CrossRefPubMedWeb of Science
10. 10.↵
    SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388–92 doi:10.1161/01.STR.0000128708.86762.d6 pmid:15105508

    Abstract/FREE Full Text
11. 11.↵
    2. Bose A,
    3. Hartmann M,
    4. Henkes H, et al

    . A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531–37 doi:10.1161/STROKEAHA.106.477711 pmid:17395864

    Abstract/FREE Full Text
12. 12.↵
    2. Jiang WJ,
    3. Xu XT,
    4. Jin M, et al

    . Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007;28:830–34 pmid:17494651

    Abstract/FREE Full Text
13. 13.↵
    2. Qureshi AI,
    3. Al-Senani FM,
    4. Husain S, et al

    . Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations. J Neuroimaging 2012;22:1–13 doi:10.1111/j.1552-6569.2011.00685.x pmid:22250951

    CrossRefPubMed
14. 14.↵
    2. Kernan WN,
    3. Ovbiagele B,
    4. Black HR, et al

    ; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160–236 doi:10.1161/STR.0000000000000024 pmid:24788967

    Abstract/FREE Full Text
15. 15.↵
    2. Fiorella D,
    3. Derdeyn CP,
    4. Lynn MJ, et al

    ; SAMMPRIS Trial Investigators. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012;43:2682–88 doi:10.1161/STROKEAHA.112.661173 pmid:22984008

    Abstract/FREE Full Text
16. 16.↵
    2. DasGupta A,
    3. Cai TT,
    4. Brown LD

    . Interval estimation for a binomial proportion. Statist Sci 2001;16:101–33 doi:10.1214/ss/1009213286

    CrossRefWeb of Science
17. 17.↵
    2. Miao Z,
    3. Song L,
    4. Liebeskind DS, et al

    . Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS. J Neurointerv Surg 2015;7:331–35 doi:10.1136/neurintsurg-2014-011109 pmid:24759694

    Abstract/FREE Full Text
18. 18.↵
    2. Jiang WJ,
    3. Cheng-Ching E,
    4. Abou-Chebl A, et al

    . Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery 2012;70:25–30; discussion 31 doi:10.1227/NEU.0b013e31822d274d pmid:21795866

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Jiang WJ,
    3. Yu W,
    4. Du B, et al

    . Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke 2011;42:1971–75 doi:10.1161/STROKEAHA.110.595926 pmid:21636814

    Abstract/FREE Full Text
20. 20.↵
    2. Siddiq F,
    3. Chaudhry SA,
    4. Khatri R, et al

    . Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice. Neurosurgery 2012;71:68–73 doi:10.1227/NEU.0b013e3182518575 pmid:22382209

    CrossRefPubMed
21. 21.↵
    2. Nahab F,
    3. Lynn MJ,
    4. Kasner SE, et al

    ; NIH Multicenter Wingspan Intracranial Stent Registry Study Group. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014–19 doi:10.1212/01.wnl.0b013e3181a1863c pmid:19299309

    Abstract/FREE Full Text
22. 22.↵
    2. Chaturvedi S,
    3. Dumont AS

    . The learning curve for neuroendovascular procedures: how important is it? Neurology 2009;72:1974–75 doi:10.1212/WNL.0b013e3181a92c6f pmid:19403883

    FREE Full Text
23. 23.↵
    2. Derdeyn CP,
    3. Fiorella D,
    4. Lynn MJ, et al

    ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery 2013;72:777–95; discussion 795 doi:10.1227/NEU.0b013e318286fdc8 pmid:23328689

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Zaidat OO,
    3. Klucznik R,
    4. Alexander MJ, et al

    ; NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24 doi:10.1212/01.wnl.0000306308.08229.a3 pmid:18235078

    Abstract/FREE Full Text
25. 25.↵
    2. Abou-Chebl A,
    3. Steinmetz H

    . Critique of “Stenting versus aggressive medical therapy for intracranial arterial stenosis” by Chimowitz et al in the New England Journal of Medicine. Stroke 2012;43:616–20 doi:10.1161/STROKEAHA.111.641563 pmid:22246688

    Abstract/FREE Full Text
26. 26.↵
    2. Hussein HM,
    3. Emiru T,
    4. Georgiadis AL, et al

    . Assessment of platelet inhibition by point-of-care testing in neuroendovascular procedures. AJNR Am J Neuroradiol 2013;34:700–06 doi:10.3174/ajnr.A2963 pmid:22422188

    Abstract/FREE Full Text
27. 27.↵
    2. Chaudhry SA,
    3. Watanabe M,
    4. Qureshi AI

    . The new standard for performance of intracranial angioplasty and stent placement after Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial. AJNR Am J Neuroradiol 2011;32:E214 doi:10.3174/ajnr.A2919 pmid:22095965

    FREE Full Text
28. 28.↵
    2. Gao P,
    3. Zhao Z,
    4. Wang D, et al

    . China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): a new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol 2015;21:196–204 doi:10.1177/1591019915581778 pmid:25934656

    Abstract/FREE Full Text